載入...
Cannabinoid Antagonist Drug Discrimination in Nonhuman Primates
Despite a growing acceptance that withdrawal symptoms can emerge following discontinuation of cannabis products, especially in high-intake chronic users, there are no Food and Drug Administration (FDA)–approved treatment options. Drug development has been hampered by difficulties studying cannabis w...
Na minha lista:
| 發表在: | J Pharmacol Exp Ther |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
The American Society for Pharmacology and Experimental Therapeutics
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6927407/ https://ncbi.nlm.nih.gov/pubmed/31641018 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.119.261818 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|